about
Client characteristics as moderators of the relation between the therapeutic alliance and outcome in cognitive therapy for depressionSafety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective studyShort-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration.It's complicated: The relation between cognitive change procedures, cognitive change, and symptom change in cognitive therapy for depression.A prognostic index (PI) as a moderator of outcomes in the treatment of depression: A proof of concept combining multiple variables to inform risk-stratified stepped care models.Cognitive-Behavioral Therapy: Nature and Relation to Non-Cognitive Behavioral Therapy.Heterogeneity in the prognosis of major depression: from the common cold to a highly debilitating and recurrent illness.Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression.Comparison of treatment outcome using two definitions of rapid cycling in subjects with bipolar II disorder.Residual anxiety may be associated with depressive relapse during continuation therapy of bipolar II depression.Effects of venlafaxine versus lithium monotherapy on quality of life in bipolar II major depressive disorder: Findings from a double-blind randomized controlled trial.Moderation of the Alliance-Outcome Association by Prior Depressive Episodes: Differential Effects in Cognitive-Behavioral Therapy and Short-Term Psychodynamic Supportive Psychotherapy.Racial and ethnic differences in risk factors associated with suicidal behavior among young adults in the USA.Are studies of psychotherapies for depression more or less generalizable than studies of antidepressants?The Generalizability of Randomized Controlled Trials of Self-Guided Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms: Systematic Review and Meta-Regression AnalysisThe Evidence for Cognitive Behavioral TherapyRecognizing that truth is unattainable and attending to the most informative research evidenceRepresenting the heterogeneity of depression in treatment researchIncrease in pharmacodynamic tolerance after repeated antidepressant trials in treatment-responsive bipolar I depressed subjects: An exploratory study
P50
Q33778084-8A4166D2-BFC8-4D29-992C-98DFF4611C9EQ35967580-88BFC93F-B9E1-4D3B-9072-8B2D00AB8E39Q36754503-069248EF-9E94-41A2-B48A-081775EA9EF2Q37452489-8A6A3563-DBF6-45BA-BBEB-5EC1184E217FQ38321335-6CF89F26-A44F-4549-8DFD-94F816D228C9Q38757175-1C23BD3B-5B08-46A9-86A4-D00326B70C0CQ39043529-27FE00EA-E366-42EA-BCAA-732D695BD4CDQ40829333-E4D21C84-CC87-4E35-8ACE-B6F8F58E5E25Q41842899-888DCD4B-38EF-40D4-9099-91ADC0FD8D65Q42771386-8F1FF432-A567-4BEA-B996-AC9FCFE3FF88Q47346845-902B057C-CCB7-4274-92D7-384CC516A096Q47577691-8AAB84C2-F132-4995-9931-B0FABF423488Q47598491-7FD552EF-A30C-418C-B268-F5EC38468C68Q47667805-FCDC8940-D8DF-4C3B-98D3-85E12BAA9FE3Q48412825-CD1F9F42-DADA-48A0-9977-19BBA807CF06Q50420137-D344C651-00D4-4DA4-A4E7-2D01F603F42CQ58566393-7B254952-F75C-47D5-96EC-C32896C5287AQ87896385-E35018E0-AC83-43DB-AAC4-B878FBC836FFQ88838072-C57E2DA3-9265-482A-A9A1-D1D1FE48A9B3Q90657132-0191917E-0BCC-48B1-A9FC-2C40130AEA6AQ91119190-F1DD8958-A33E-4AD7-9538-E4244C4B9850
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8882-0243
@en
name
Lorenzo Lorenzo-Luaces
@ast
Lorenzo Lorenzo-Luaces
@en
Lorenzo Lorenzo-Luaces
@es
Lorenzo Lorenzo-Luaces
@nl
type
label
Lorenzo Lorenzo-Luaces
@ast
Lorenzo Lorenzo-Luaces
@en
Lorenzo Lorenzo-Luaces
@es
Lorenzo Lorenzo-Luaces
@nl
prefLabel
Lorenzo Lorenzo-Luaces
@ast
Lorenzo Lorenzo-Luaces
@en
Lorenzo Lorenzo-Luaces
@es
Lorenzo Lorenzo-Luaces
@nl
P106
P21
P31
P496
0000-0002-8882-0243